Nitric oxide in occurrence, progress and therapy of lung cancer: A systemic review and meta-analysis
BMC Cancer — Zhou H, Li J, Chen Z, et al. | June 10, 2021
Whether and how nitric oxide (NO) is associated with lung cancer, was investigated via this meta-analysis. Relevant studies were found via comprehensive exploration in the databases. Overall 50 studies with 2551 cases and 1691 controls were analyzed. Much higher FeNO (fraction of exhaled nitric oxide) and blood NO levels were detected in lung cancer patients in comparison to that in controls. The highest blood NO level was observed in large cell carcinoma patients. FeNO and blood NO level did not differ significantly between pretreatment and posttreatment in all patients. However, NSCLC (non- small cell lung cancer) patients exhibited an increase in FeNO level and decline in blood NO level post-therapy. These findings indicate that FeNO and blood NO level would contribute to lung cancer diagnosis as well as assessment of treatment impact, particularly for NSCLC cases.
Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.
Turn Off Ad Blocker
We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.